SANXING(SH:601567) Xin Lang Cai Jing·2025-11-07 03:08Core Viewpoint - Samsung Medical's stock has experienced fluctuations, with a year-to-date decline of 9.68% but a recent recovery of 18.47% over the last five trading days [1] Group 1: Financial Performance - For the period from January to September 2025, Samsung Medical reported a revenue of 11.08 billion, representing a year-on-year growth of 6.19%, while the net profit attributable to shareholders decreased by 15.85% to 1.528 billion [2] - The company has distributed a total of 6.407 billion in dividends since its A-share listing, with 3.329 billion distributed over the last three years [3] Group 2: Stock Market Activity - As of November 7, Samsung Medical's stock price was 26.55, with a trading volume of 570 million and a turnover rate of 1.50%, leading to a total market capitalization of 37.308 billion [1] - The stock has seen significant net outflows of 34.124 million from main funds, with large orders buying 138 million and selling 127 million [1] Group 3: Business Overview - Samsung Medical, established on February 1, 2007, and listed on June 15, 2011, primarily engages in the research, production, and sales of electric energy metering and information collection products, as well as distribution equipment [2] - The company's revenue composition includes 79.70% from the electric power sector, 19.15% from medical services, and 1.15% from other business activities [2]